Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Shlipak

Showing results (1-10 of 601) with videos related to

Pageof 61
Sort By:
Annals of Internal Medicine|June 5, 2003
Pharmacotherapy for heart failure in patients with renal insufficiencyMichael G Shlipak
Nature Clinical Practice. Nephrology|February 10, 2007
Cystatin C as a marker of glomerular filtration rate in chronic kidney disease: influence of body compositionMichael G Shlipak
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2008
Cystatin C: research priorities targeted to clinical decision makingMichael G Shlipak
Clinical Journal of the American Society of Nephrology : CJASN|May 17, 2015
Should Hemoglobin A1C Be Routinely Measured in Patients with CKD?Nisha Bansal, Michael G Shlipak
Current Opinion in Nephrology and Hypertension|September 2, 2020
Cystatin C is ready for clinical useNatalie Ebert, Michael G Shlipak
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2016
Kidney Disease, Income, and Life ExpectancyJoshua Lang, Michael G Shlipak
Nature Reviews. Nephrology|May 13, 2015
Risk factors: Individual assessment of CKD risk in HIV-positive patientsRebecca Scherzer, Michael G Shlipak
Hypertension (Dallas, Tex. : 1979)|August 30, 2008
Hypertension in children with chronic kidney disease: a call to actionCarmen A Peralta, Michael G Shlipak
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 20, 2024
The New Cardiovascular-Kidney-Metabolic (CKM) Syndrome: An Opportunity for CKD Detection and Treatment in Primary CareSara-Megumi Rumrill, Michael G Shlipak
Journal of the American Geriatrics Society|September 24, 2022
Age-adapted eGFR thresholds underestimate the risks beyond kidney failure associated with CKD in older populationsJennifer S Lees, Michael G Shlipak
Pageof 61

Showing results (1-10 of 601) with videos related to

Sort By:
Pageof 61
Annals of Internal Medicine|June 5, 2003
Pharmacotherapy for heart failure in patients with renal insufficiencyMichael G Shlipak
Nature Clinical Practice. Nephrology|February 10, 2007
Cystatin C as a marker of glomerular filtration rate in chronic kidney disease: influence of body compositionMichael G Shlipak
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2008
Cystatin C: research priorities targeted to clinical decision makingMichael G Shlipak
Clinical Journal of the American Society of Nephrology : CJASN|May 17, 2015
Should Hemoglobin A1C Be Routinely Measured in Patients with CKD?Nisha Bansal, Michael G Shlipak
Current Opinion in Nephrology and Hypertension|September 2, 2020
Cystatin C is ready for clinical useNatalie Ebert, Michael G Shlipak
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2016
Kidney Disease, Income, and Life ExpectancyJoshua Lang, Michael G Shlipak
Nature Reviews. Nephrology|May 13, 2015
Risk factors: Individual assessment of CKD risk in HIV-positive patientsRebecca Scherzer, Michael G Shlipak
Hypertension (Dallas, Tex. : 1979)|August 30, 2008
Hypertension in children with chronic kidney disease: a call to actionCarmen A Peralta, Michael G Shlipak
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 20, 2024
The New Cardiovascular-Kidney-Metabolic (CKM) Syndrome: An Opportunity for CKD Detection and Treatment in Primary CareSara-Megumi Rumrill, Michael G Shlipak
Journal of the American Geriatrics Society|September 24, 2022
Age-adapted eGFR thresholds underestimate the risks beyond kidney failure associated with CKD in older populationsJennifer S Lees, Michael G Shlipak
Pageof 61